ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1816

Single-Cell RNA-Transcriptomics of JDM Skin Identifies JDM-Associated Immune Cell Populations and Dysregulated Interferon Signaling in Immune and Endothelial Cells

Chioma Madubata1, Jessica Neely2, Christine Goudsmit3, Celine Berthier4, Zilan Zheng5, Sophia Matossian4, Jeffrey Dvergsten6, Andrew Heaton7, J. Michelle Kahlenberg4, Gabrielle Fragiadakis8 and Jessica Turnier9, 1UCSF, SF, CA, 2UCSF, San Francisco, CA, 3University of Michigan, Ann Arbor, 4University of Michigan, Ann Arbor, MI, 5University of California, San Francisco, San Francisco, CA, 6Duke University Hospital, Hillsborough, NC, 7Cure JM Foundation, Anthony, FL, 8UCSF, San Francisco, 9University of Michigan, Saline, MI

Meeting: ACR Convergence 2025

Keywords: dermatomyositis, Gene Expression, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1809–1829) Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Juvenile dermatomyositis (JDM) is the most common idiopathic inflammatory myopathy in children. JDM often presents with rash, and skin inflammation is more refractory to treatment compared to muscle inflammation. Treatments are limited due to incomplete understanding of disease pathogenesis, including under-explored analysis of the cellular composition of lesional skin, exacerbated by a lack of access to pediatric tissue. Therefore, we assembled a cohort of archival JDM skin biopsies and performed single-nuclei RNA-sequencing for an unbiased analysis of skin-specific cellular and transcriptomic drivers of JDM.

Methods: Single nuclei RNA was isolated from formalin-fixed paraffin-embedded (FFPE) skin biopsies using the 10X Genomics Flex platform; the cohort included patients with JDM (n=12) and controls (CTL, n=4). All JDM patients met 2017 EULAR/ACR classification criteria, and 11/12 were treatment-naïve at sampling. We used SoupX to remove ambient RNA, and DoubletFinder to remove doublets. We performed UMAP dimensionality reduction and Louvain clustering with Seurat. Cell clusters were annotated using published cell type-specific marker genes. Analysis of differentially expressed genes (DEG) was performed using Model-based Analysis of Single-cell Transcriptomics. Cell type abundance between JDM and CTL was analyzed with Milo and the Wilcoxon rank sum test. Gene set scores were calculated using the Seurat AddModuleScore() function. Given clinical differences between skin and muscle inflammation in JDM, we compared our skin data to a single-nuclear RNA-sequencing dataset from JDM (n=6) and control (n=7) muscle biopsy samples.

Results: From the 91,216 cells analyzed, we identified 14 major cell types (Fig 1a,b) and 20 unique cell clusters (Fig 1c). JDM samples showed increased abundance of immune cells compared to CTL (Fig 2a,b). Analysis of cellular neighborhoods also identified subsets of neighborhoods with consistently higher abundance of JDM in immune cell types (Fig 2c,d). Keratinocytes, melanocytes, endothelial cells, and macrophages showed the highest number of differentially expressed genes (Fig 3a). In all skin cell types, JDM samples had higher average expression of Interferon (IFN)-response genes (IRG) compared to CTL (Fig 3b). Endothelial cells showed the highest median IRG set expression in both JDM skin (Fib 3b) and muscle (Fig 3c), with many IRG demonstrating differential expression in both skin and muscle endothelial cells (Fig 3d,e).

Conclusion: Single cell skin transcriptomics in JDM highlights dysregulated immune and endothelial cell populations contributing to disease pathogenesis. Altered IFN is a hallmark of JDM skin tissue, with macrophages, melanocytes, and endothelial cells exhibiting the highest levels of IRG expression. While all cell types show high IRG expression in JDM, endothelial cells exhibit the highest median IRG expression in both muscle and skin. This unique single-cell atlas of JDM skin will generate critical hypotheses for investigating cellular mechanisms of JDM rash and vasculopathy and for identifying targeted therapies.

Supporting image 1Fig 1. Single cell transcriptomics of JDM skin identifies keratinocyte, endothelial, and immune cell populations. a) UMAP plot colored by cell type. b) UMAP plot colored by cell cluster fine annotation. c) Dot plot of expression for cell type marker genes.

Supporting image 2Fig 2. Immune cell clusters and neighborhoods show high abundance of cells from JDM samples. a,b) Boxplots representing the fraction (a) and number (b) of cells that come from immune cell types among all JDM or CTL cells; p-value from Wilcoxon rank-sum test. c) Neighborhood graph from Milo showing log2(fold change) of cell abundance of JDM vs CTL within a neighborhood of cells. Each node is a neighborhood of cells, with edges indicating cells in common between two neighborhoods. Graph layout reflects the position of each neighborhood’s index cell within the UMAP embedding in 1a. d) Right panel) Beeswarm Milo plots showing distribution of log2(fold change) of cell abundance in neighborhoods, grouped by the majority cell type within a neighborhood (>70% of cells). Left panel) Boxplots representing the fraction of cells that come from each cell type among all JDM or CTL cells; + indicates p-value < 0.05 from Wilcoxon rank-sum test, * indicates FDR < 0.05 after Benjamini-Hochberg.

Supporting image 3Fig 3. Endothelial cells exhibit high differential expression of IFN-response genes in both muscle and skin JDM samples. a) Number of differentially expressed genes (DEG) in each cell type that show increased expression in JDM or CTL. b,c) IRG score for b) skin samples and c) an outside muscle biopsy single-nuclei RNA-seq dataset. Scores are calculated using 28 IRG from Kim et al 2018. Dots indicate the median IRG score across all cells in a cell type from CTL samples (X-axis) and JDM samples (Y-axis); lines indicate interquartile range. d) Scatterplot comparing the log2(fold change) values of DEG analysis in muscle (X-axis) and skin (Y-axis); DEG criteria is FDR < 0.05, absolute(log2(fold change)) >0.1. e) Venn diagram comparing DEG in outside muscle data set and skin JDM atlas.


Disclosures: C. Madubata: None; J. Neely: None; C. Goudsmit: None; C. Berthier: None; Z. Zheng: None; S. Matossian: None; J. Dvergsten: None; A. Heaton: None; J. Kahlenberg: AstraZeneca, 1, Aurinia Pharmaceuticals, 1, Avion Pharmaceuticals, 1, Biogen, 1, Boehringer-Ingelheim, 1, Bristol-Myers Squibb(BMS), 1, 5, Danger Bio, 1, Eli Lilly, 1, Exo Therapeutics, 2, GlaxoSmithKlein(GSK), 2, Janssen, 5, Provention Bio, 1, Q32 Bio, 5, Rome Therapeutics, 2, 5, Ventus, 2, 5; G. Fragiadakis: None; J. Turnier: Cabaletta Bio, 2.

To cite this abstract in AMA style:

Madubata C, Neely J, Goudsmit C, Berthier C, Zheng Z, Matossian S, Dvergsten J, Heaton A, Kahlenberg J, Fragiadakis G, Turnier J. Single-Cell RNA-Transcriptomics of JDM Skin Identifies JDM-Associated Immune Cell Populations and Dysregulated Interferon Signaling in Immune and Endothelial Cells [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/single-cell-rna-transcriptomics-of-jdm-skin-identifies-jdm-associated-immune-cell-populations-and-dysregulated-interferon-signaling-in-immune-and-endothelial-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-rna-transcriptomics-of-jdm-skin-identifies-jdm-associated-immune-cell-populations-and-dysregulated-interferon-signaling-in-immune-and-endothelial-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology